Sascha Macherey-Meyer
Overview
Explore the profile of Sascha Macherey-Meyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Outpatient diuretic intensification: a simple prognostic marker in cardiac transthyretin amyloidosis
Nies R, Ney S, Nies J, Seuthe K, Klosges L, Bruwer M, et al.
Clin Res Cardiol
. 2025 Mar;
PMID: 40035810
Background: Currently, simple clinical parameters indicating disease progression are lacking in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). This study aimed to evaluate the prognostic value of outpatient diuretic intensification (ODI)...
2.
Braumann S, Macherey-Meyer S, Polzin A, Costard-Jackle A, Morbach C, Haring B, et al.
Circulation
. 2025 Feb;
PMID: 39937049
No abstract available.
3.
Guthoff H, Lohner V, Mons U, Gotz J, Wienemann H, Wrobel J, et al.
Infection
. 2025 Feb;
PMID: 39918726
Purpose: Elevations in inflammatory markers after transcatheter aortic valve replacement (TAVR) often lead to preemptive antibiotic therapy (ABT). Distinguishing between physiological inflammatory reaction and true infection is crucial for rational...
4.
Macherey-Meyer S, Terporten J, Adler C
Dtsch Arztebl Int
. 2025 Jan;
121(20):680.
PMID: 39804205
No abstract available.
5.
Macherey-Meyer S, Heyne S, Meertens M, Finke K, Mauri V, Ahrens I, et al.
Dtsch Arztebl Int
. 2024 Oct;
121(25):833-839.
PMID: 39475751
Background: Patients with ST-segment elevation myocardial infarction (STEMI) are often pretreated with unfractionated heparin (UFH) before a primary percutaneous coronary intervention (PPCI). UFH pretreatment is intended to lessen the thrombotic...
6.
Heyne S, Macherey-Meyer S, Meertens M, Finke K, Baldus S, Adler C, et al.
Clin Res Cardiol
. 2024 Sep;
PMID: 39297938
Background: Left ventricular thrombus (LVT) is associated with high rates of systemic embolism. Vitamin K antagonists (VKAs) are the only approved treatment for LVT. Although evidence suggests direct oral anticoagulant...
7.
Genske F, Rawish E, Macherey-Meyer S, Buchel C, Dejanovikj M, Jurczyk D, et al.
Hellenic J Cardiol
. 2024 Aug;
PMID: 39094787
Objectives: Right heart catheterization (RHC) is a common diagnostic tool and of special importance in the diagnosis of pulmonary hypertension (PH). Until today, there have been no clear instructions or...
8.
Macherey-Meyer S, Salem K, Heyne S, Meertens M, Finke K, Mauri V, et al.
J Clin Med
. 2024 May;
13(10).
PMID: 38792462
Chronic total occlusion (CTO) is a prevalent finding in patients with coronary artery disease and is associated with increased mortality. Prior reports on the efficacy of percutaneous coronary intervention (PCI)...
9.
Macherey-Meyer S, Adam M, Mauri V
Dtsch Arztebl Int
. 2024 Feb;
120(51-52):890.
PMID: 38315657
No abstract available.
10.
Langenbach M, Langenbach I, Foldyna B, Mauri V, Klein K, Macherey-Meyer S, et al.
Eur Radiol
. 2024 Jan;
34(8):4897-4908.
PMID: 38189982
Background: Coronary artery disease (CAD) and severe aortic valve stenosis (AS) frequently coexist. While pre-transcatheter aortic valve replacement (TAVR) computed tomography angiography (CTA) allows to rule out obstructive CAD, interpreting...